Literature DB >> 21472198

Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance.

Beom J Lim1, Sung S Jung, Song Y Choi, Choong S Lee.   

Abstract

Molecules associated with tumor invasion and metastasis have been actively investigated, but their prognostic significance has been variously reported by investigators. We evaluated the expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-3, MMP-9, MMP-10, tissue inhibitor of MMPs (TIMP)-1, TIMP-2, β-catenin, E-cadherin and cyclooxygenase-2 (COX-2) in 43 cases of non-small cell lung cancer (NSCLC). Immunohistochemistry of each marker was performed on tissue microarray paraffin blocks, and the results were determined by a semi-quantitative method using an intensity score (0-3) and percentage score (0-3). The expression scores of each marker were correlated with TNM stage and patient survival data. The expression of MMP-3 and COX-2 was significantly increased in higher stage tumors (P<0.001 and P=0.046, respectively), while a correlation with patient survival length was observed for MMP-1 and COX-2 (P=0.034 and 0.019, respectively). All stage I or II cases with increased MMP-1 expression succumbed to NSCLC within 34.1 months. Cases with low expression of both MMP-1 and COX-2 had a significantly longer survival time than cases with high expression of either of the two markers (P=0.002). These results suggest that MMP-1 and COX-2 are plausible candidate survival markers for NSCLC.

Entities:  

Year:  2010        PMID: 21472198     DOI: 10.3892/mmr_00000216

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  A meta-analysis of abnormal β-catenin immunohistochemical expression as a prognostic factor in lung cancer: location is more important.

Authors:  Y Yang; J Shen; Jiaxi He; Jianxing He; G Jiang
Journal:  Clin Transl Oncol       Date:  2015-10-12       Impact factor: 3.405

2.  Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis.

Authors:  Kunpeng Ma; Limin Ma; Zhaocheng Jian
Journal:  Oncol Lett       Date:  2018-05-18       Impact factor: 2.967

3.  Efficacy of DC-CIK-based immunotherapy combined with chemotherapy in the treatment of intermediate to advanced non-small cell lung cancer.

Authors:  Ling Wang; Yue Dai; Fuliang Zhu; Zhimin Qiu; Yaqi Wang; Yinghui Hu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

4.  The stromelysin-1 5A/5A genotype enhances colorectal cancer cell invasion in Iranian population.

Authors:  Majid Motovali-Bashi; Zohreh Hojati; Samaneh Hajihoseiny; Simin Hemmati
Journal:  J Res Med Sci       Date:  2012-10       Impact factor: 1.852

Review 5.  Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Lin Zhu; Hong Yu; Shi-Yuan Liu; Xiang-Sheng Xiao; Wei-Hua Dong; Yi-Nan Chen; Wei Xu; Tong Zhu
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

6.  Levuglandin forms adducts with histone h4 in a cyclooxygenase-2-dependent manner, altering its interaction with DNA.

Authors:  Erica J Carrier; Irene Zagol-Ikapitte; Venkataraman Amarnath; Olivier Boutaud; John A Oates
Journal:  Biochemistry       Date:  2014-04-11       Impact factor: 3.162

7.  TREM-1 is induced in tumor associated macrophages by cyclo-oxygenase pathway in human non-small cell lung cancer.

Authors:  Zhihong Yuan; Hiren J Mehta; Kamal Mohammed; Najmunissa Nasreen; Robert Roman; Mark Brantly; Ruxana T Sadikot
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

8.  Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.

Authors:  Shan-Shan Sun; Xuan Zhou; Yuan-Yuan Huang; Ling-Ping Kong; Mei Mei; Wen-Yu Guo; Ming-Hui Zhao; Yu Ren; Qiang Shen; Lun Zhang
Journal:  Mol Cancer       Date:  2015-12-21       Impact factor: 27.401

Review 9.  Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Liang Gong; Dan Wu; Jianding Zou; Jianqiang Chen; Liangyu Chen; Yun Chen; Chao Ni; Hongjun Yuan
Journal:  Oncotarget       Date:  2016-04-05

10.  HER2 induces cell proliferation and invasion of non-small-cell lung cancer by upregulating COX-2 expression via MEK/ERK signaling pathway.

Authors:  Feng Chi; Rong Wu; Xueying Jin; Min Jiang; Xike Zhu
Journal:  Onco Targets Ther       Date:  2016-05-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.